Abbott Laboratories (ABT) Latest Company News

Aug 31, 2026, 12:00 UTC
Abbott launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula made with whole milk in the U.S., at a price similar to its existing Similac powdered formula, available online and at major U.S. retailers.
Source:
- prnewswire.com
- wsoctv.com
Aug 28, 2026, 00:18 UTC
China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.
Source:
- finance.sina.cn
Aug 27, 2026, 13:03 UTC
Abbott's next-generation Amulet 360™ occluder received CE marking for treating atrial fibrillation patients at risk of stroke.
Source:
- finance.sina.cn
- prnewswire.com
Aug 25, 2026, 18:49 UTC
Abbott received FDA authorization for its Libre Duo 10 Day system, the world's first dual glucose-ketone sensing biowearable for people with diabetes.
Source:
Aug 25, 2026, 08:09 UTC
Gateway Wealth Partners LLC reduced its stake in Abbott Laboratories by 64.3% during the quarter, selling 15,431 shares and retaining 8,564 shares, according to a recent SEC filing.
Source:
- defenseworld.net
Aug 25, 2026, 08:09 UTC
Choreo LLC reduced its stake in Abbott Laboratories by 4.4% during the second quarter, selling 4,580 shares, as disclosed in its 13F filing.
Source:
- defenseworld.net
Aug 25, 2026, 08:09 UTC
Golden Reserve Retirement LLC increased its stake in Abbott Laboratories by 155.2% during the quarter, acquiring 5,557 additional shares to hold 9,138 shares, as disclosed in its Form 13F filing.
Source:
- defenseworld.net
Aug 20, 2026, 20:16 UTC
Abbott agreed to pay $670 million to settle part of the infant formula claims lawsuit.
Source:
Aug 20, 2026, 19:51 UTC
HealthTab, a subsidiary of Avricore Health, signed a distribution agreement with Abbott to supply and distribute Abbott's point-of-care testing products, including the Afinion 2 Analyzer, in the UK.
Source:
- 360dx.com
Aug 20, 2026, 17:15 UTC
Medtronic's MiniMed Flex insulin pump system, paired with Abbott's 15-day Instinct sensor, is now shipping in the United States.
Source:
- zacks.com
Aug 17, 2026, 09:56 UTC
Fifth Third Wealth Advisors LLC reduced its holdings in Abbott Laboratories by 32.6% during the second quarter, selling 14,830 shares and retaining 30,646 shares, as disclosed in its Form 13F filing.
Source:
- defenseworld.net
Aug 11, 2026, 14:00 UTC
The first bellwether trial in the federal multidistrict litigation over necrotizing enterocolitis claims against the makers of Enfamil and Similac is set to begin this week, with jury selection scheduled after several delays.
Source:
- aboutlawsuits.com
- thewhig.com
Aug 11, 2026, 13:02 UTC
Abbott announced a partnership with Google to conduct a large-scale metabolic health research study.
Source:
Jul 27, 2026, 12:00 UTC
The FDA approved Freenome's SimpleScreen CRC blood-based screening test, and Abbott will commercialize it in the U.S.
Source:
- globenewswire.com
- reuters.com
Jul 24, 2026, 19:58 UTC
A patient filed a class action lawsuit against Abbott Laboratories and Exact Sciences in Illinois federal court, alleging failure to safeguard sensitive personal and health information in a data theft hack claimed by ShinyHunters.
Source:
- databreachtoday.com
Jul 16, 2026, 12:35 UTC
Abbott's cancer diagnostics business suffered a cybersecurity incident; the incident did not affect operations or product supply.
Source:
Jul 16, 2026, 00:00 UTC
Abbott Laboratories reported its Q2 2026 financial results, with revenue of $12.593 billion and GAAP diluted EPS of $0.53, and updated its full-year 2026 adjusted diluted EPS guidance to a range of $5.45 to $5.60.
Source:
Jul 7, 2026, 11:10 UTC
Insulet launched its Omnipod 5 automated insulin delivery system in Spain.
Source:
- finance.yahoo.com
- zacks.com
Jun 29, 2026, 01:17 UTC
The U.S. Department of Justice closed a criminal probe into Abbott Laboratories over its management of a baby formula plant and opted for civil penalties instead.
Source:
- reuters.com
Jun 24, 2026, 11:36 UTC
ALZpath signed a global licensing agreement with Abbott Laboratories to develop a blood-based test for Alzheimer's disease.
Source:
- reuters.com
Jun 12, 2026, 18:29 UTC
Abbott's board of directors declared a quarterly common dividend of 63 cents per share.
Source:
- prnewswire.com
Jun 5, 2026, 17:57 UTC
A U.S. federal judge ruled that consumers could reasonably interpret Abbott's marketing of PediaSure as promising height growth, allowing a lawsuit to proceed.
Source:
- benzinga.com
- reuters.com

ABT

Abbott launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula made with whole milk in the U.S., at a price similar to its existing Similac powdered formula, available online and at major U.S. retailers.

China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.

Abbott's next-generation Amulet 360™ occluder received CE marking for treating atrial fibrillation patients at risk of stroke.

Abbott received FDA authorization for its Libre Duo 10 Day system, the world's first dual glucose-ketone sensing biowearable for people with diabetes.

Gateway Wealth Partners LLC reduced its stake in Abbott Laboratories by 64.3% during the quarter, selling 15,431 shares and retaining 8,564 shares, according to a recent SEC filing.

Choreo LLC reduced its stake in Abbott Laboratories by 4.4% during the second quarter, selling 4,580 shares, as disclosed in its 13F filing.

Golden Reserve Retirement LLC increased its stake in Abbott Laboratories by 155.2% during the quarter, acquiring 5,557 additional shares to hold 9,138 shares, as disclosed in its Form 13F filing.

Abbott agreed to pay $670 million to settle part of the infant formula claims lawsuit.

HealthTab, a subsidiary of Avricore Health, signed a distribution agreement with Abbott to supply and distribute Abbott's point-of-care testing products, including the Afinion 2 Analyzer, in the UK.

Medtronic's MiniMed Flex insulin pump system, paired with Abbott's 15-day Instinct sensor, is now shipping in the United States.

Fifth Third Wealth Advisors LLC reduced its holdings in Abbott Laboratories by 32.6% during the second quarter, selling 14,830 shares and retaining 30,646 shares, as disclosed in its Form 13F filing.

The first bellwether trial in the federal multidistrict litigation over necrotizing enterocolitis claims against the makers of Enfamil and Similac is set to begin this week, with jury selection scheduled after several delays.

Abbott announced a partnership with Google to conduct a large-scale metabolic health research study.

The FDA approved Freenome's SimpleScreen CRC blood-based screening test, and Abbott will commercialize it in the U.S.

A patient filed a class action lawsuit against Abbott Laboratories and Exact Sciences in Illinois federal court, alleging failure to safeguard sensitive personal and health information in a data theft hack claimed by ShinyHunters.

Abbott's cancer diagnostics business suffered a cybersecurity incident; the incident did not affect operations or product supply.

Abbott Laboratories reported its Q2 2026 financial results, with revenue of $12.593 billion and GAAP diluted EPS of $0.53, and updated its full-year 2026 adjusted diluted EPS guidance to a range of $5.45 to $5.60.

Insulet launched its Omnipod 5 automated insulin delivery system in Spain.

The U.S. Department of Justice closed a criminal probe into Abbott Laboratories over its management of a baby formula plant and opted for civil penalties instead.

ALZpath signed a global licensing agreement with Abbott Laboratories to develop a blood-based test for Alzheimer's disease.

Abbott's board of directors declared a quarterly common dividend of 63 cents per share.

A U.S. federal judge ruled that consumers could reasonably interpret Abbott's marketing of PediaSure as promising height growth, allowing a lawsuit to proceed.